Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Affluent Medical is a clinical-stage French MedTech company developing minimally invasive, biomimetic and adjustable implants for mitral valve repair and replacement and for treatment of urinary incontinence. All three core products (Kalios mitral annuloplasty device, Epygon transcatheter mitral valve and Artus artificial urinary sphincter) are in human clinical studies in Europe, with Kalios targeting FDA De Novo submission end of 2025 and Artus entering pivotal trials in 2025, while Epygon is completing a pilot phase with promising early performance data.[1][3][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Affluent Medical.